Cargando…
Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways
A member of the Janus kinase (JAK) family, Tyrosine Kinase 2 (TYK2), is crucial in mediating various cytokine-signaling pathways such as interleukin-23 (IL23), interleukin-12 (IL12) and type I Interferons (IFN) which contribute to autoimmune disorders (e.g., psoriasis, lupus, and inflammatory bowel...
Autores principales: | Zhou, Yu, Li, Xin, Shen, Ru, Wang, Xiangzhu, Zhang, Fan, Liu, Suxing, Li, Di, Liu, Jian, Li, Puhui, Yan, Yinfa, Dong, Ping, Zhang, Zhigao, Wu, Heping, Zhuang, Linghang, Chowdhury, Rasheduzzaman, Miller, Matthew, Issa, Mena, Mao, Yuchang, Chen, Hongli, Feng, Jun, Li, Jing, Bai, Chang, He, Feng, Tao, Weikang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186491/ https://www.ncbi.nlm.nih.gov/pubmed/35693820 http://dx.doi.org/10.3389/fimmu.2022.884399 |
Ejemplares similares
-
SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis
por: Song, Chunying, et al.
Publicado: (2022) -
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast Cancer
por: Liu, Suxing, et al.
Publicado: (2021) -
Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage
por: Li, Zhi, et al.
Publicado: (2020) -
TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020) -
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
por: Prchal-Murphy, Michaela, et al.
Publicado: (2015)